Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Havrix Junior Monodose vaccine suspension for injection 0.5ml vials (GlaxoSmithKline UK Ltd) 1 vial |
Has dispensed dose form |
True |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Technetium [Tc-99m] labelled human albumin macroaggregates suspension for injection |
Has dispensed dose form |
True |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Technetium [Tc-99m] labelled red blood cells suspension for injection |
Has dispensed dose form |
True |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Technetium[99mTc] albumin colloid (nanosized) injection |
Has dispensed dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Triesence 40mg/1ml suspension for injection vials (Alcon Laboratories (UK) Ltd) |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Triesence 40mg/1ml suspension for injection vials (Alcon Laboratories (UK) Ltd) |
Has dispensed dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Triamcinolone acetonide 40mg/1ml suspension for injection vials 1 vial |
Has dispensed dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Triesence 40mg/1ml suspension for injection vials (Alcon Eye Care UK Ltd) 1 vial |
Has dispensed dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Prolonged-release suspension for injection |
Is a |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
VAQTA Adult vaccine suspension for injection 1ml vials (Organon Pharma (UK) Ltd) |
Has dispensed dose form |
True |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
VAQTA Adult vaccine suspension for injection 1ml vials (Organon Pharma (UK) Ltd) 1 vial |
Has dispensed dose form |
True |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Human papillomavirus (type 6, 11, 16, 18, 31, 33, 45, 52, 58) vaccine (adsorbed) suspension for injection 0.5ml pre-filled syringes |
Has dispensed dose form |
True |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Gardasil 9 vaccine suspension for injection 0.5ml pre-filled syringes (Merck Sharp & Dohme (UK) Ltd) |
Has dispensed dose form |
True |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Human papillomavirus (type 6, 11, 16, 18, 31, 33, 45, 52, 58) vaccine (adsorbed) suspension for injection 0.5ml pre-filled syringes 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Gardasil 9 vaccine suspension for injection 0.5ml pre-filled syringes (Merck Sharp & Dohme (UK) Ltd) 1 pre-filled disposable injection |
Has dispensed dose form |
True |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane bovine 100units/ml suspension for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic porcine 30/70 100units/ml suspension for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane porcine 100units/ml suspension for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Hepatitis B (rDNA) vaccine suspension for injection 5micrograms/0.5ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Hepatitis A (inactivated) vaccine suspension for injection 0.5ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Diphtheria (adsorbed) / Tetanus / Pertussis (acellular) vaccine suspension for injection 0.5ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Hepatitis B (rDNA) vaccine suspension for injection 10micrograms/1ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Hepatitis B (rDNA) vaccine suspension for injection 40micrograms/1ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Hepatitis B (rDNA) vaccine suspension for injection 10micrograms/0.5ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Pneumococcal polysaccharide conjugated vaccine suspension for injection 0.5ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane human 100units/ml suspension for injection 10ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane human 100units/ml suspension for injection 5ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane human 100units/ml suspension for injection 1.5ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 25/75 100units/ml suspension for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 25/75 100units/ml suspension for injection 5ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 20/80 100units/ml suspension for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 25/75 100units/ml suspension for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 10/90 100units/ml suspension for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 20/80 100units/ml suspension for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic porcine 30/70 100units/ml suspension for injection 10ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 20/80 100units/ml suspension for injection 1.5ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 10/90 100units/ml suspension for injection 1.5ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 10/90 100units/ml suspension for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 15/85 100units/ml suspension for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 50/50 100units/ml suspension for injection 10ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 30/70 100units/ml suspension for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 40/60 100units/ml suspension for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 15/85 100units/ml suspension for injection 5ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 50/50 100units/ml suspension for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 30/70 100units/ml suspension for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 50/50 100units/ml suspension for injection 1.5ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 15/85 100units/ml suspension for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 40/60 100units/ml suspension for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 50/50 100units/ml suspension for injection 5ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 30/70 100units/ml suspension for injection 10ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 30/70 100units/ml suspension for injection 1.5ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin lispro biphasic 25/75 100units/ml suspension for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin lispro biphasic 25/75 100units/ml suspension for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin lispro biphasic 50/50 100units/ml suspension for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin aspart biphasic 30/70 100units/ml suspension for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic porcine 30/70 100units/ml suspension for injection 1.5ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin aspart biphasic 30/70 100units/ml suspension for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 50/50 100units/ml suspension for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane bovine 100units/ml suspension for injection 1.5ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane bovine 100units/ml suspension for injection 10ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin zinc mixed bovine 100units/ml suspension for injection 10ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane porcine 100units/ml suspension for injection 1.5ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane porcine 100units/ml suspension for injection 10ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin isophane biphasic human 40/60 100units/ml suspension for injection 1.5ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Tetracosactide 1mg/1ml suspension for injection ampoules |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Tick-borne encephalitis (inactivated) vaccine suspension for injection 0.5ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Cytarabine 50mg/5ml intrathecal suspension for injection vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Poliomyelitis (inactivated) vaccine suspension for injection 0.5ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Diphtheria / Tetanus / Pertussis / Poliomyelitis (inactivated) / Haemophilus type b conjugate vaccine (adsorbed) suspension for injection 0.5ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Diphtheria / Tetanus / Pertussis (acellular, component) / Poliomyelitis (inactivated) vaccine (adsorbed) suspension for injection 0.5ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Anthrax vaccine suspension for injection 0.5ml ampoules |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Hepatitis A HM175 strain (adsorbed) / Typhoid polysaccharide vaccine suspension for injection 1ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Hepatitis A GBM strain (adsorbed) / Typhoid polysaccharide vaccine suspension for injection 1ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Influenza (split virion, inactivated) vaccine suspension for injection 0.25ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic Pollinex Grasses + Rye No 1 vaccine suspension for injection 1ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic Pollinex Grasses + Rye No 2 vaccine suspension for injection 1ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic Pollinex Grasses + Rye No 3 vaccine suspension for injection 1ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic Pollinex Grasses + Rye Extension Course vaccine suspension for injection 1.5ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic Pollinex Trees No 1 vaccine suspension for injection 1ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic Pollinex Trees No 2 vaccine suspension for injection 1ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic Pollinex Trees No 3 vaccine suspension for injection 1ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Generic Pollinex Trees Extension Course vaccine suspension for injection 1.5ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Tick-borne encephalitis (inactivated) vaccine suspension for injection 0.25ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Pneumococcal polysaccharide conjugated vaccine (adsorbed) suspension for injection 0.5ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Influenza vaccine (surface antigen, inactivated, virosome) suspension for injection 0.5ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin lispro biphasic 50/50 100units/ml suspension for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Procaine benzylpenicillin 1.5g/3.4ml suspension for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Hepatitis B (rDNA) 5micrograms/0.5ml vaccine suspension for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Hepatitis B (rDNA) 10micrograms/1ml vaccine suspension for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Human papillomavirus vaccine (adsorbed) suspension for injection 0.5ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Human papillomavirus (type 16, 18) vaccine (adsorbed) suspension for injection 0.5ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Paliperidone 50mg/0.5ml prolonged-release suspension for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Paliperidone 75mg/0.75ml prolonged-release suspension for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Paliperidone 100mg/1ml prolonged-release suspension for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Paliperidone 150mg/1.5ml prolonged-release suspension for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Hepatitis A (inactivated) / Hepatitis B (rDNA) vaccine (adsorbed) suspension for injection 1ml vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Fluspirilene 12mg/6ml suspension for injection vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Medroxyprogesterone 104mg/0.65ml suspension for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Japanese encephalitis vaccine (inactivated, adsorbed) suspension for injection 0.5ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Morphine sulphate 10mg/1ml suspension for injection vials |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|
Influenza vaccine (split virion, inactivated) suspension for injection 0.1ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release suspension for injection |
Inferred relationship |
Existential restriction modifier |
|